Apeloa Pharmaceutical Co.,Ltd
000739
Κατάταξη σε μετοχές
#4291
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Τιμή μετοχής
$3.13
Κεφαλαιοποίηση
$3.62B
Αλλαγή (1 ημέρα)
-1.42%
Αλλαγή (1 έτος)
46.59%
Χώρα
CN
Εμπόριο Apeloa Pharmaceutical Co.,Ltd (000739)
Κατηγορία
Healthcare
Δείκτης P/B για Apeloa Pharmaceutical Co.,Ltd (000739)
Δείκτης P/B στις October 2026 TTM: 3.59
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της Apeloa Pharmaceutical Co.,Ltd, ο τρέχων δείκτης P/B (TTM) είναι 3.59. Στο τέλος του 2024, η εταιρεία είχε P/B δείκτη 2.79.
Ιστορικό P/B για την Apeloa Pharmaceutical Co.,Ltd από 2000 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
| Έτος | Δείκτης P/B | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 3.59 | 21.27% |
| 2025 | 2.96 | 5.96% |
| 2024 | 2.79 | -4.02% |
| 2023 | 2.91 | -36.30% |
| 2022 | 4.57 | -44.09% |
| 2021 | 8.17 | 30.79% |
| 2020 | 6.25 | 54.03% |
| 2019 | 4.06 | 55.35% |
| 2018 | 2.61 | 6.58% |
| 2017 | 2.45 | -25.52% |
| 2016 | 3.29 | -15.47% |
| 2015 | 3.89 | 8.52% |
| 2014 | 3.59 | 61.94% |
| 2013 | 2.21 | 84.56% |
| 2012 | 1.20 | -71.82% |
| 2011 | 4.26 | 43.16% |
| 2010 | 2.97 | -10.68% |
| 2009 | 3.33 | 131.56% |
| 2008 | 1.44 | -62.40% |
| 2007 | 3.82 | 20.96% |
| 2006 | 3.16 | 103.63% |
| 2005 | 1.55 | -23.64% |
| 2004 | 2.03 | -11.01% |
| 2003 | 2.29 | -41.50% |
| 2002 | 3.91 | -43.69% |
| 2001 | 6.94 | 17.81% |
| 2000 | 5.89 | 0.00% |
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Δείκτης P/B | Διαφορά Δείκτη P/B | Χώρα |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| 1.3124 | -63.44% |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 40.43% |
IN
|
